| Not Yet Recruiting | JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD Erosive Gastroesophageal Reflux Disease | — | 2025-08-25 |
| Completed | Observationa Study is a Prospective and Multi-institutional Observational Study. Erosive Reflux Disease, Heartburn, Acid Regurgitation | — | 2024-11-01 |
| Recruiting | To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-200 Healthy | Phase 1 | 2024-04-23 |
| Unknown | Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients Type 2 Diabetes Mellitus | Phase 2 | 2023-11-01 |
| Completed | To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-200 Healthy Adult | Phase 1 | 2023-10-05 |
| Completed | To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP- Healthy Adult | Phase 1 | 2022-05-03 |
| Unknown | To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Co Type 2 Diabetes Mellitus | Phase 3 | 2022-04-05 |
| Completed | To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901 Healthy Adult | Phase 1 | 2022-02-15 |
| Unknown | To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately C Type 2 Diabetes Mellitus | Phase 3 | 2021-11-17 |
| Unknown | A Study of Lubiprostone to Treat Constipation Constipation | — | 2021-09-01 |
| Completed | The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers Overactive Bladder(OAB) | Phase 1 | 2021-03-13 |
| Unknown | Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy Subjects Diabetes Mellitus | Phase 1 | 2020-11-24 |
| Completed | To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder Overactive Bladder | Phase 3 | 2020-05-21 |
| Completed | The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Hea Hypertension With Dyslipidemia | Phase 1 | 2018-12-13 |
| Completed | The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Diabetes, Hyperlipidemias | Phase 1 | 2018-10-04 |
| Completed | Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Or Anti-Ulcer Agents | Phase 1 | 2017-12-22 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma Hepatocellular Carcinoma Non-resectable | N/A | 2017-10-25 |
| Completed | Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers Diabetes, Hyperlipidemia | Phase 1 | 2017-08-02 |
| Completed | The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Diabetes, Hyperlipidemia | Phase 1 | 2017-07-06 |
| Completed | Compare the Pharmacokinetic Characteristics and the Safety Between Zeropix and Champix in Healthy Adult Male S Smoking, Cigarette | Phase 1 | 2017-07-06 |
| Completed | The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Hea Hypertension With Dyslipidemia | Phase 1 | 2017-06-10 |
| Completed | Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adul Hypertension With Hyperlipidemia | Phase 1 | 2017-05-07 |
| Unknown | Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke Acute Ischemic Stroke | Phase 2 | 2016-12-09 |
| Completed | Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma Hepatocellular Carcinoma Non-resectable | N/A | 2016-12-05 |
| Completed | Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin Dyslipidemia With Hypertension | Phase 3 | 2016-09-20 |
| Completed | Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia | Phase 3 | 2016-02-01 |
| Completed | Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia Type 2 Diabetes, Dyslipidemia | Phase 3 | 2016-01-15 |
| Completed | The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. LUTS(Lower Urinary Tract Symptoms), Benign Prostatic Hyperplasia, Overactive Bladder | Phase 1 | 2015-08-01 |
| Completed | Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers LUTS, Benign Prostatic Hyperplasia, Overactive Bladder | Phase 1 | 2015-07-01 |
| Completed | The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunt Stroke | Phase 1 | 2015-03-01 |
| Completed | The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine Hypertension, Hyperlipidemia | Phase 1 | 2015-02-01 |
| Completed | Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin Hyperlipidemia, Diabetes | Phase 1 | 2014-08-01 |
| Completed | Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin LUTS, Benign Prostatic Hyperplasia, Overactive Bladder | Phase 1 | 2014-07-01 |
| Completed | The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers Stroke | Phase 1 | 2013-11-01 |
| Completed | Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Sten ANEURYSM CORONARY ARTERY | Phase 4 | 2012-11-01 |
| Completed | Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets Essential Hypertension | Phase 2 | 2007-11-01 |